The Extraordinary General Meeting of Navamedic ASA has elected Kathryn M. Baker as Chairman of the Board of Directors and Jostein Davidsen as a new board member. Kathryn M. Baker brings extensive board experience to the Chairman position, currently serving on the Executive Board of the Central Bank of Norway, as well as on the boards of Catena Media, Akastor ASA, DOF ASA, and Sevan Marine ASA. Prior to that, she was a management consultant at McKinsey & Co in Oslo and a financial analyst at Morgan Stanley in New York. Baker has also held several advisory board positions, including for the Tuck School of Business, DLA Piper Norway, and the Ethics Committee of the Norwegian Private Equity and Venture Capital Association. The election follows the decision of longstanding Chairman of the Navamedic board, Johan Reinsli, to step down due to an increased workload in other areas. Reinsli will continue as a member of the board. Jostein Davidsen brings more than 30 years of experience from the international pharmaceuticals industry, most recently serving as the Chief Executive Officer of the Acino Pharmaceuticals in Switzerland. Mr. Davidsen was the founder of Nycomed Russia. Davidsen served after the transaction as a Corporate Officer and the Head of the Emerging Markets at Takeda Pharmaceuticals International based in Zurich.